Releases
RCEL
--
0.00%
--
  • All
  • Financials
  • Insiders
Webull provides the latest Avita Medical (RCEL) stock and general news. This information may help you make smarter investment decisions.
About RCEL
AVITA Medical Inc., formerly AVITA Therapeutics, Inc., is a regenerative medicine company with a technology platform to address medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. Its technology provides treatment solutions derived from the regenerative properties of a patient’s own skin. The medical devices work by preparing Spray-On Skin Cells, an autologous cellular suspension comprised of the patient’s skin cells necessary to regenerate natural healthy epidermis. It has developed RECELL System, a product for the treatment of acute thermal burn injuries in patients 18 years and older. The RECELL System is used to prepare Spray-On Skin Cells using a small amount of a patient’s own skin, providing a way to treat severe burns that significantly reduces the amount of donor skin required. It can be used at the point of care alone or in combination with split-thickness skin autografts depending on the depth of the burn injury.